Successful Treatment of Refractory Autoimmune Hemolytic Anemia With Monthly Rituximab Following Nonmyeloablative Stem Cell Transplantation for Sickle Cell Disease
Authors:
- Salvatore BertoloneSBSalvatore Bertolone
- Alexandra CheervaACAlexandra Cheerva
- 1 May 2004
- journal article
- case report
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 26 (5) , 312-314
Abstract
Autoimmune hemolytic anemia (AIHA) can occur following hematopoietic stem cell transplantation (HSCT) and may be associated with other cytopenias. It can also occur in the context of chronic red cell transfusion in patients maintained on hypertransfusion regimens. There are an increasing number of reports on the successful treatment of autoimmune cytopenias with the monoclonal anti-CD20 antibody rituximab, including a few patients in a post-HSCT setting. The authors report the successful treatment with rituximab of refractory AIHA following allogeneic nonmyeloablative bone marrow transplantation in a child with sickle cell disease.Keywords
This publication has 8 references indexed in Scilit:
- Mechanism of action and resistance to monoclonal antibody therapySeminars in Oncology, 2003
- Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and β-thalassemiaTransplantation and Cellular Therapy, 2003
- Delayed Hemolytic Transfusion Reaction/Hyperhemolysis Syndrome in Children With Sickle Cell DiseasePediatrics, 2003
- Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximabBone Marrow Transplantation, 2002
- Anti-CD20 monoclonal antibody therapy for autoimmune hemolytic anemia following T cell-depleted, haplo-identical stem cell transplantationBone Marrow Transplantation, 2002
- Prospective RBC phenotype matching in a stroke‐prevention trial in sickle cell anemia: a multicenter transfusion trialTransfusion, 2001
- Bone Marrow Transplantation without Myeloablation for Sickle Cell DiseaseNew England Journal of Medicine, 2001
- Late onset haemolysis and red cell autoimmunisation after allogeneic bone marrow transplantBone Marrow Transplantation, 1997